2006
DOI: 10.1016/j.yrtph.2006.01.005
|View full text |Cite
|
Sign up to set email alerts
|

Biomonitoring: Is body burden relevant to public health?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
22
0
1

Year Published

2011
2011
2021
2021

Publication Types

Select...
5
3
2

Relationship

0
10

Authors

Journals

citations
Cited by 51 publications
(23 citation statements)
references
References 25 publications
0
22
0
1
Order By: Relevance
“…Making sense of biomarker measurements, especially in the context of children's exposure, is not straightforward. Results can be influenced by a myriad of factors, including: the time of day or season of the year a sample was collected; the time between exposure and sample collection; the quantity of the sample available for analysis; the specificity and sensitivity of a particular biologic marker; concurrent or sequential exposure to other environmental agents; and the nutritional status of the subject (Needham and Sexton, 2000;Barr et al, 2005;Paustenbach and Galbraith, 2006). Moreover, observed differences between biomarker measurements made (1) multiple times in the same child over a defined period (W-CV) or (2) once in numerous children at approximately the same time (B-CV) can be because of dissimilarities in actual exposures, variations in pharmacokinetics, or a combination of both (Needham and Sexton, 2000;Barr et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…Making sense of biomarker measurements, especially in the context of children's exposure, is not straightforward. Results can be influenced by a myriad of factors, including: the time of day or season of the year a sample was collected; the time between exposure and sample collection; the quantity of the sample available for analysis; the specificity and sensitivity of a particular biologic marker; concurrent or sequential exposure to other environmental agents; and the nutritional status of the subject (Needham and Sexton, 2000;Barr et al, 2005;Paustenbach and Galbraith, 2006). Moreover, observed differences between biomarker measurements made (1) multiple times in the same child over a defined period (W-CV) or (2) once in numerous children at approximately the same time (B-CV) can be because of dissimilarities in actual exposures, variations in pharmacokinetics, or a combination of both (Needham and Sexton, 2000;Barr et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…Once the reference limits for a metal in the general population are described, they may serve as a basis for a deeper evaluation of the observed values after environmental or professional exposures or in case of diseases, physiological changes, effectiveness of medical therapies, etc. [1][2][3][4].…”
Section: Introductionmentioning
confidence: 99%
“…Making connections between the exposome and risk assessment is a difficult but important venture (Paustenbach and Galbraith 2006; Rappaport and Smith 2010). Risk assessments typically examine the effects of high doses of administered chemicals to determine the lowest observed adverse effect levels (LOAELs) and no observed adverse effect levels (NOAELs); reference doses, which are assumed safe for human exposure, are then calculated from these doses using a number of safety factors.…”
mentioning
confidence: 99%